Member Info for The-Oracle

Who makes the last sell before the RNS.

And y'all leave SCHeckler alone, he's been here since we used to forrage for scraps in the tips in cambridge.

And well done Leggster

Courtesy of Citizen79

Mcap is in the billions btw

Experimental drug compares favorably against Keytruda in late-stage trial, Summit says

Shares of Summit Therapeutics Inc. (SMMT) jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc.'s blockbuster Keytruda in a late-stage clinical trial.

In June it is then

We might still be in the early days.

As we all hope with the coming data and the deals it brings. While Aim is it's own death spiral, covid spikes over and most wallowing in endless placings.

Looking forward to Sareum taking the stage, at home and abroad. No cross ramps will be needed, from more HNWIs to institutions.

The Yanks have woken

Giddy up Sar, lets go

Brace yourselves folks

Honestly, the first few weeks to months of this trial were sweaty af. I hazard a guess we are well past the point of adverse news.

F site

Damn this stupid site on a phone

Data may not be due for public consumption by end of june. To avoid chaos on this board and potentially give a spanner to the wombles. We are not hosting the Bio World Conference whose date is set without anything to do with Sareum. We are just attending so news from data has nothing to do with it. Building that expectation is dangerous.

Honestly it's not far away. 5 more weeks tops minus this week. Plenty of time to take a position and relax.

Gla

Damn this stupid site on a phone

Data may not be due for public consumption by end of june. To avoid chaos on this board and potentially give a spanner to the wombles. We are not hosting the Bio World Conference whose da

Data may not be due for public consumption by end of june. To avoid chaos on this board and potentially give a spanner to the wombl

Yh HBD, well if someone else decides to take the whole house, they will be better off. I know these pharmas behave like us, you see a company, you know you want to buy, wait like a buffoon until it clines some 20% and then start sweating and hit buy at 30% plus and blame the f zodiac.

Sorry all. As much as I would love to get an offer £5 plus tomorrow to put me out of my misery. Am also greedy. So, wouldn't mind an extra year if we can get 1801 into p2, funds from that deal to get 1802 into p2 too.

I want a yuge payout, been here too long. If it means one more year so be it.

Who ever has 737 has no rights over us or what we do with 1801. I am still confused as to why the upfront for 737 wasn't significantly higher.

I mean access to 737 shouldn't stop others from offering something for 1801/02

Majority of shares now in sticky hands.

Going to be an interesting few weeks to say the least.

How soon?

Gla

CORRECTION is what we are witnessing Lsesar.

1801 may not get a chance to be factored in. We should be multiples of this minus rf and this whole farce.

Boyasaka You sound like you believe in the potential of Sareum.

Almost irritated at the progress in sp. Can't decide what you are doing. So will you sell your 8k at double or will you hold because you believe like everyone else the mcap is worth hundreds of millions.

Some could have easily taken their capital at 20p and left the equivalent amount in profit. Also a worthy option.

Or let SAR do what it historically does and mulitbag after multibag. People might think covid is back. Some Millionaires have invested at multiples of this. We are the lucky ones.

Am not selling a bean till the fat lady sings

We are severely undervalued Boyasaka don't you believe.

With all that's on the table. Sp and mcap should be significantly higher.

Sareum is worth so much more wouldn't you agree.

Here it comes, hold the line

Can't afford to be out of this overnight.

Cheers Potnak,

Not pump and dump imo, just the sp correcting, rf are out. Confidence with anticipation is driving this. Traders will take as we go along. We've been miles higher with far less progress so.